Literature DB >> 2169903

A novel transcriptional regulatory factor that binds to the polyoma virus enhancer in a developmental stage-specific manner.

T Hirano1, Y Iwakura.   

Abstract

By using gel mobility shift assay, it was shown that the nuclear extract from F9 embryonal carcinoma (EC) cells contains a novel transcriptional regulatory factor, BF-H, that binds to the 5' upstream region of the early gene of polyoma virus. Two binding sites were located in the transcriptional enhancer domain "A" (nucleotide 5034-5041) and in the 5' upstream of the domain "A" (4998-5005), having a consensus motif (AAPuATGG) between them. Combination of in vitro mutagenesis with chloramphenicol acetyltransferase (CAT) assay revealed that BF-H is a positive transcriptional factor. Interestingly, the binding of BF-H disappeared after differentiation of F9 cells by treatment with retinoic acid, whereas BF-H was present in the F9 cells differentiated with both retinoic acid and dibutyryl cyclic AMP (dbcAMP). These observations suggest that BF-H regulates the expression of genes in a developmental stage-specific manner in early embryos of the mouse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169903     DOI: 10.1016/0300-9084(90)90028-f

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity.

Authors:  B T Lamb; K Satyamoorthy; L Li; D Solter; C C Howe
Journal:  Gene Expr       Date:  1991

2.  An enhancer of recombination in polyomavirus DNA.

Authors:  D Gendron; L Delbecchi; D Bourgaux-Ramoisy; P Bourgaux
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  CRA-1 uncovers a double-strand break-dependent pathway promoting the assembly of central region proteins on chromosome axes during C. elegans meiosis.

Authors:  Sarit Smolikov; Kristina Schild-Prüfert; Mónica P Colaiácovo
Journal:  PLoS Genet       Date:  2008-06-06       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.